Acquisitions25 May 2026, 09:31 pm
Entero Healthcare to Acquire Vishal Surgicals via Subsidiary
AI Summary
Entero Healthcare Solutions Ltd's subsidiary, Sai Pharma Distributors Private Limited, will acquire Vishal Surgicals and Vishal Surgicals & Medicals, a Partnership Firm, through a Slump Sale / Business Transfer Agreement (BTA). The Board of Directors also approved the audited financial results for the quarter and financial year ended March 31, 2026, and re-appointed Mr. Sujesh Vasudevan, Mr. Rajesh Shashikant Dalal, and Ms. Sandhya Gadkari Sharma as Non-Executive Independent Directors. Additionally, the board approved the allotment of 7,240 Equity Shares under the Entero Employee Stock Option Plan 2023 and noted the grant of fresh 7,300 Employee Stock Options.
Key Highlights
- Sai Pharma Distributors to acquire Vishal Surgicals through Slump Sale.
- Board approved audited financial results for FY26.
- Re-appointment of three Non-Executive Independent Directors approved.
- Allotment of 7,240 Equity Shares under ESOP 2023 approved.
- Grant of 7,300 Employee Stock Options noted by the Board.